New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
09:12 EDTOWW, ORCL, KBH, PSUN, HZNP, EXAS, RENN, RBCNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: KB Home (KBH), up 7%...Pacific Sunwear (PSUN), up 7%. ALSO HIGHER: Horizon Pharma (HZNP), up 23% after deal to acquire Ireland's Vidara Therapeutics through reverse merger... Exact Sciences (EXAS), up 6.5% after a clinical trial of its Cologuard test, which it co-developed with the Mayo Clinic, showed "unprecedented" rates of precancer and cancer detection by a noninvasive test... DOWN AFTER EARNINGS: Oracle (ORCL), down 3.3%... Renren (RENN), down 7%. ALSO LOWER: Orbitz (OWW), down 5.4% after Goldman downgraded shares to Sell from Neutral... Rubicon (RBCN), down 6% after 2.5M share spot secondary offering priced at $13.00.
News For OWW;ORCL;KBH;PSUN;HZNP;EXAS;RENN;RBCN From The Last 14 Days
Check below for free stories on OWW;ORCL;KBH;PSUN;HZNP;EXAS;RENN;RBCN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
08:00 EDTEXASExact Sciences price target raised to $28 from $22 at JMP Securities
JMP Securities increased its price target on Exact Sciences as the firm, after conducting channel checks, estimates that ColoGuard will sell for $375. The firm continues to recommend buying shares of the stock.
07:36 EDTHZNPHorizon Pharma issued USPTO Notice of Allowance fpr Rayos tablets
Subscribe for More Information
August 26, 2014
17:33 EDTORCLOracle initiated with a Neutral at DA Davidson
Subscribe for More Information
16:22 EDTOWWOn The Fly: Closing Wrap
Subscribe for More Information
16:20 EDTOWWOrbitz issues statement regarding American Airlines action
Subscribe for More Information
16:14 EDTOWWOrbitz FY14 outlook at risk due to American dispute, says Cantor
Subscribe for More Information
12:24 EDTOWWOn The Fly: Midday Wrap
Subscribe for More Information
12:17 EDTOWWAmerican Airlines fares no longer available on Orbitz websites
Subscribe for More Information
07:46 EDTEXASExact Sciences price target raised to $23 from $21 at Canaccord
Canaccord raised its price target on Exact Sciences to $23 from $21 following yesterday's announcement the Mayo Clinic will adopt Cologuard. The firm believes there is the potential for additional healthcare systems to come on board as the publicity raises awareness among primary care doctors. Canaccord keeps its Buy rating on shares of Exact Sciences.
August 25, 2014
19:10 EDTRENNRenren sees Q3 revenue $19M-$21M, consensus $22.94M
19:09 EDTRENNRenren reports Q2 EPS 9c, consensus (7c)
Subscribe for More Information
15:18 EDTRENNNotable companies reporting after market close
Subscribe for More Information
11:26 EDTEXASOptions with increasing implied volatility: EXAS FTR PSEC
Subscribe for More Information
August 22, 2014
13:49 EDTORCLOregon sues Oracle over health exchange website
Subscribe for More Information
13:31 EDTEXASExact Sciences test not reimbursed by Aetna, says Maxim
Subscribe for More Information
11:26 EDTORCLSalesforce.com rallies following beat and raise quarter
Subscribe for More Information
10:07 EDTEXASOptions with increasing implied volatility: ORPH EXAS AZN
Subscribe for More Information
08:38 EDTOWWTripAdvisor cut metasearch inventory in half, says FBR Capital
Subscribe for More Information
August 20, 2014
11:47 EDTEXASOptions with increasing implied volatilit
Subscribe for More Information
August 18, 2014
08:05 EDTEXASExact Sciences risk/reward positive, says Canaccord
Canaccord said the scenario analysis of upcoming catalysts suggests positive risk/reward for the shares of Exact Sciences. The firm cited its potential for reimbursement approvals form both the CMS and commercial payers. Shares of Exact Sciences remain Buy rated with a $21 price target.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use